ADHD and Sleep Bedtime Problems Restless Nights and Daytime Focus

Last Reviewed on July 9, 2026
Reviewd By Burton J. Tabaac, MD, FAHA"
July 9, 2026

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

ADHD can affect sleep by making bedtime harder, delaying task stopping, increasing nighttime restlessness and making mornings more difficult. You may stay up because time slips away, your thoughts speed up at night, your body feels restless or your medication timing needs review. Poor sleep can then worsen focus, impulse control, mood, school performance, work output and daily routines.

Sleep and ADHD often affect each other. ADHD can make it harder to settle at night. Poor sleep can make ADHD symptoms feel stronger the next day. You may have more distractibility, irritability, forgetfulness, emotional reactions and late starts after a short or broken night.

The pattern matters. A single late night does not mean ADHD is causing sleep trouble. A repeated pattern of delayed bedtime, restless nights, hard mornings and daytime focus problems deserves review. A clinician can help check ADHD symptoms, sleep habits, medication timing, anxiety, depression, substance use and medical sleep disorders.

Children, teens and adults can all have ADHD related sleep strain. A child may resist bedtime, leave bed often or wake tired for school. A teen may stay up with screens, homework or racing thoughts. An adult may feel tired but unable to stop tasks, scroll late or lie awake thinking through unfinished work.

Fast answer for ADHD and sleep

ADHD and sleep problems often occur together. You may have trouble going to bed, falling asleep, staying asleep, waking up or feeling alert in the morning. ADHD can affect sleep through time blindness, restless thoughts, physical restlessness, poor routine cues and medication timing. Sleep problems can also come from insomnia, sleep apnea, restless legs syndrome, anxiety, depression or substance use.

If you have ADHD insomnia, the first step is to track the pattern. Write down bedtime, wake time, sleep quality, naps, caffeine, screen use, medication timing, exercise, alcohol or cannabis use and morning function. This record can help your clinician see what may be driving the problem.

Daily changes can help, but ongoing sleep problems should be reviewed medically. You may need a medication timing review, sleep disorder screening, therapy for anxiety or depression, a bedtime routine or a different support plan for mornings.

You should seek prompt medical care for breathing pauses during sleep, loud snoring with daytime sleepiness, sudden sleep attacks, severe restless legs, dangerous sleepwalking, major mood changes, suicidal thoughts or any symptom that feels unsafe.

Bedtime delay and racing thoughts

Bedtime delay is common when ADHD affects time sense and task stopping. You may plan to sleep at a certain time, then lose track of time while working, scrolling, cleaning, gaming or finishing one more task. The delay may not feel intentional. The clock may simply stop feeling real until it is very late.

Racing thoughts can also appear at night. The quiet part of the day may bring up unfinished tasks, conversations, mistakes, plans or worries. You may feel tired but mentally active. You may replay the day, plan tomorrow or jump between thoughts that do not settle.

For children, bedtime delay may look like repeated requests, leaving the bed, talking, playing or needing many reminders. For teens, it may look like late screen use, homework done too late or shifting sleep times on weekends. For adults, it may look like revenge bedtime delay after a demanding day, late productivity or losing hours to a phone.

A bedtime routine works best when it begins before you are already exhausted. Set a shutdown cue. This may be an alarm labeled with the next action, such as wash face, set clothes out or plug in phone outside the bed. The cue should tell you exactly what to do.

Why stopping is hard

ADHD can make stopping harder than starting. Once your brain is engaged, switching away from an activity may feel uncomfortable. You may keep going because the current task has momentum, while sleep feels less immediate.

Stopping also requires planning. You must notice the time, judge what can wait, tolerate the unfinished task and shift into a quieter routine. Each step can be harder when executive function is strained.

A simple shutdown routine

A shutdown routine should be short. Choose a few steps that repeat in the same order.

  • Check tomorrow’s first commitment
  • Put keys, wallet, bag and medication in their place
  • Set clothes or school items out
  • Put the phone away from the bed
  • Start the same quiet activity each night

The routine should not become a full house reset. It should help your brain leave the day without opening more tasks.

Restlessness and poor sleep quality

ADHD restlessness can affect sleep quality. You may feel physically tense, shift often, tap your feet, need to move or feel unable to settle. In adults, restlessness may feel internal. In children, it may appear as moving around the bed, getting up or resisting stillness.

Poor sleep quality can mean you spend enough hours in bed but still wake tired. You may wake often, toss and turn or feel mentally active through the night. You may also have another sleep disorder that needs testing.

Restlessness can be worse when the day had too little movement, too much stimulation, high stress or late caffeine. It can also be linked with anxiety, restless legs syndrome, medication effects or sleep schedule drift.

A calmer evening routine can help some people. This may include dimmer lights, lower stimulation, a warm shower, light stretching, reading something easy or listening to steady audio. The routine should be consistent enough that your body learns the cue.

Children who keep leaving bed

A child with ADHD may leave bed repeatedly because stillness is hard, the routine is unclear or the child receives attention each time they get up. A clear bedtime order can help. Use short instructions, a visual chart and calm return to bed.

Praise the first part of the routine that goes well. If the child brushes teeth, gets into pajamas or stays in bed for a short period, name that success. Children with ADHD often need immediate feedback.

Adults who feel tired but wired

Adults may describe feeling tired but wired. Your body may be exhausted, but your mind keeps moving. A written worry list or task capture can help. Put tomorrow’s tasks in one place before bed so your brain does not have to keep repeating them.

If this happens most nights, discuss it with a clinician. Anxiety, medication timing, substance use, sleep disorders and mood symptoms may need review.

Medication timing and clinician review

ADHD medication can affect sleep for some people. The effect depends on the medicine, dose, timing, formulation, age, sleep history and individual response. Some people sleep better when ADHD symptoms are controlled during the day. Others may have insomnia, appetite changes or evening rebound symptoms.

Do not change medication timing, dose or type without your prescriber. If sleep becomes worse after starting or changing medication, record the pattern and contact the clinician. Note when you take the medication, when focus improves, when symptoms return, when sleepiness starts and when you fall asleep.

Some people have evening rebound, where symptoms return as medicine wears off. This can bring irritability, restlessness, hunger or poor focus near bedtime. The answer is not always taking more medicine. The prescriber needs to review the full pattern.

Children need monitoring for sleep, appetite, growth, mood, heart rate and blood pressure when medication is used. Adults may need monitoring for sleep, blood pressure, pulse, anxiety, mood, appetite, substance risk and daily function.

What to tell the prescriber

Bring clear details to the visit.

  • Medication name and dose
  • Time taken
  • Time symptoms improve
  • Time symptoms return
  • Bedtime and wake time
  • Night wakings
  • Appetite changes
  • Mood changes
  • Caffeine use
  • Alcohol, cannabis or nicotine use
  • School or work effects

This information helps the prescriber decide if timing, dose, formulation or another part of the plan needs review.

Morning routines and school or work strain

Poor sleep often shows up the next morning. You may hit snooze several times, run late, forget items, skip breakfast or start the day in conflict. Children may struggle to get dressed, eat, pack bags or leave on time. Teens may miss school start times. Adults may arrive late, open work slowly or lose the first part of the day.

ADHD can make mornings harder because they require many steps in a short time. You must wake, shift attention, move through hygiene, find items, eat, prepare and leave. Poor sleep lowers the energy needed for each step.

Morning routines should be prepared the night before when possible. Put clothing, school items, work items, keys, wallet and medication in fixed places. Use a visible checklist. Keep breakfast simple. Set alarms that name the action, not only the time.

For children, morning instructions should be short. One step at a time may work better than a full list. For teens, shared planning may work better than repeated reminders. For adults, a fixed launch spot and limited morning decisions can reduce late starts.

School strain

A child who sleeps poorly may look more inattentive, emotional or hyperactive at school. Teachers may see poor focus, movement, irritability or falling asleep. If this pattern repeats, the care plan should include sleep review, not only behavior correction.

Work strain

Adults may lose work time through slow starts, missed meetings, low focus and task switching. If sleep is poor, productivity tools may fail because the body is under rested. Addressing sleep can make ADHD supports work better.

Sleep problems that may need testing

Some sleep problems need medical testing or specialist review. ADHD can coexist with sleep disorders, and symptoms can overlap. Poor sleep can look like ADHD, and ADHD can make sleep worse.

Talk with a clinician if you snore loudly, stop breathing during sleep, wake gasping, have morning headaches or feel very sleepy during the day. These can point to sleep apnea.

Ask about restless legs syndrome if you have uncomfortable leg sensations at night that improve with movement. Periodic limb movement during sleep may also disturb sleep quality.

Discuss circadian rhythm problems if your sleep schedule is consistently delayed and hard to shift. Some people with ADHD have a strong late sleep pattern, especially teens and adults.

Seek review for insomnia if you regularly have trouble falling asleep, staying asleep or waking too early with daytime impairment. Anxiety, depression, pain, medications, caffeine and substances may contribute.

When to seek urgent help

Seek urgent help if sleep problems come with suicidal thoughts, self harm urges, hallucinations, mania symptoms, severe confusion, fainting, chest pain, dangerous sleep behavior or any immediate safety concern.

Routine ADHD sleep planning should wait until immediate safety is addressed.

Daily steps that make sleep easier

Daily steps work best when they are small, repeated and tied to real cues. The aim is to reduce bedtime friction, lower stimulation and make tomorrow easier.

Start with a stable wake time. Wake time is often easier to control than sleep time. A steady wake time can help your body learn the rhythm, though shift work, illness and caregiving can make this harder.

Use morning light when possible. Light helps cue the sleep wake cycle. A short walk, sitting near natural light or opening blinds may help your body register morning.

Limit late caffeine. Caffeine can worsen insomnia for some people, especially when used later in the day. Track timing and effects so you can discuss them with a clinician.

Move earlier in the day if you can. Physical activity can help with restlessness and sleep pressure. Late intense exercise may make sleep harder for some people, so track your response.

Put tasks to bed. Write tomorrow’s first three actions on paper or in one task system. This can reduce the need to mentally repeat tasks at night.

Make screens less central at bedtime. If stopping screen use is hard, set the phone to charge away from bed, use app limits or place a different low stimulation activity near the bed.

Prepare for tomorrow. Place items near the door, pack school or work bags and set clothing out. This reduces morning stress and gives your brain fewer reasons to stay alert at night.

Psychedelic research has brought serious scientific attention to therapeutic support, emotional processing and mental flexibility. For ADHD and sleep, current care should rely on established sleep assessment, ADHD treatment review and clinician guided support.

Conclusion

As you review ADHD and sleep, bedtime routines and current research limits, we at Rose Hill Life Sciences follow related questions through our work as a psychedelic research organization focused on the production and research of Psilocybe cubensis, with our role at the intersection of science and therapeutic integration reflected in our Massachusetts research work.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.